Skip to main content
. 2015 Sep 4;16(1):101. doi: 10.1186/s12931-015-0267-6

Fig. 1.

Fig. 1

Study design. COPD = chronic obstructive pulmonary disease; DPI = dry-powder inhaler; FF = fluticasone furoate; GP = general practitioner; ICS = inhaled corticosteroid; LABA = long-acting β2-agonist; LAMA = long-acting muscarinic antagonist; Rx = treatment; VI = vilanterol